PORZIO, Rosa
 Distribuzione geografica
Continente #
NA - Nord America 203
EU - Europa 193
AS - Asia 95
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 495
Nazione #
US - Stati Uniti d'America 201
CN - Cina 79
IE - Irlanda 53
SE - Svezia 51
IT - Italia 41
FI - Finlandia 28
DE - Germania 10
SG - Singapore 7
TR - Turchia 5
CI - Costa d'Avorio 3
CZ - Repubblica Ceca 3
FR - Francia 3
IN - India 3
BE - Belgio 2
CA - Canada 2
NL - Olanda 2
A1 - Anonimo 1
IR - Iran 1
Totale 495
Città #
Dublin 53
Chandler 51
Ann Arbor 20
Dearborn 17
Parma 17
Beijing 15
New York 14
Ashburn 13
Shanghai 12
Nanjing 11
Princeton 8
Seattle 7
Jinan 6
Izmir 5
Wilmington 4
Abidjan 3
Bremen 3
Changsha 3
Hebei 3
Hefei 3
Nanchang 3
Shenyang 3
Singapore 3
Woodbridge 3
Boardman 2
Brussels 2
Des Moines 2
Fremont 2
Guangzhou 2
Mestre 2
Modena 2
Rockville 2
Tianjin 2
Carlentini 1
Casalgrande 1
Fuzhou 1
Haikou 1
Hangzhou 1
Helsinki 1
Henderson 1
Jiaxing 1
Lanzhou 1
Leawood 1
Ningbo 1
Norwalk 1
Ottawa 1
Redwood City 1
Rio Saliceto 1
San Mateo 1
Taiyuan 1
Taizhou 1
Toronto 1
Verona 1
Xian 1
Totale 319
Nome #
High levels of Notch intracellular cleaved domain are associated with stemness and reduced bevacizumab efficacy in patients with advanced colon cancer 89
Notch expression and bevacizumab efficacy in colorectal cancer patients 75
P-027Cancer stem cells marker CD44 and Notch activation predict unfavorable prognosis in metastatic colon cancer patients treated with anti VEGF-therapy 71
Strong Notch activation hinders bevacizumab efficacy in advanced colorectal cancer 70
Cancer stem cells related marker CD44 and Notch activation in metastatic colon cancer patients 61
Notch Activation Modulates Bevacizumab Activity by CD44 Positive Cancer Stem Cells in Advanced Colon Cancer 57
Prognostic impact of interval breast cancer detection in women with pT1aN0M0 breast cancer with HER2-positive status: results from a multicenter population-based cancer registry study 47
Phase II study of eribulin in combination with gemcitabine for the treatment of patients with locally advanced or metastatic triple negative breast cancer: ERIGE trial on behalf of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC) 39
Totale 509
Categoria #
all - tutte 1.864
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.864


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202093 13 5 0 7 6 18 7 2 4 28 3 0
2020/202140 4 5 1 1 4 3 1 7 6 2 5 1
2021/202235 2 0 0 5 2 0 2 2 1 1 2 18
2022/2023176 18 24 12 10 11 21 3 10 61 0 6 0
2023/202467 0 7 0 1 5 25 7 8 2 1 3 8
2024/20256 6 0 0 0 0 0 0 0 0 0 0 0
Totale 509